The presence or absence of a retroviral long terminal repeat influences the genetic risk for type 1 diabetes conferred by human leukocyte antigen DQ haplotypes. Belgian Diabetes Registry

MLA

H, Donner, et al. “The Presence or Absence of a Retroviral Long Terminal Repeat Influences the Genetic Risk for Type 1 Diabetes Conferred by Human Leukocyte Antigen DQ Haplotypes. Belgian Diabetes Registry.” The Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 4, Apr. 1999. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c730b7c068d957f4dfd19190a7822c4b&authtype=sso&custid=ns315887.

APA

H, D., R R, T., B, V. der A., T, S., J, B., I, W., J, H., R, K., K H, U., & K, B. (1999). The presence or absence of a retroviral long terminal repeat influences the genetic risk for type 1 diabetes conferred by human leukocyte antigen DQ haplotypes. Belgian Diabetes Registry. The Journal of Clinical Endocrinology and Metabolism, 84(4).

Chicago

H, Donner, Tönjes R R, Van der Auwera B, Siegmund T, Braun J, Weets I, Herwig J, Kurth R, Usadel K H, and Badenhoop K. 1999. “The Presence or Absence of a Retroviral Long Terminal Repeat Influences the Genetic Risk for Type 1 Diabetes Conferred by Human Leukocyte Antigen DQ Haplotypes. Belgian Diabetes Registry.” The Journal of Clinical Endocrinology and Metabolism 84 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........c730b7c068d957f4dfd19190a7822c4b&authtype=sso&custid=ns315887.